Paclitaxel-loaded ethosomes®: Potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 81, Issue 1, 2012, Pages 102-112

  Paolino, Donatella ^a,b   Celia, Christian ^a   Trapasso, Elena ^a   Cilurzo, Felisa ^a   Fresta, Massimo ^a,b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b Research Foundation for the Cure and Treatment of Tumors Tommaso Campanella   (Italy)

Author keywords

Actinic keratoses; Ethosomes ; Improved percutaneous permeation; Paclitaxel; Skin cancer diseases; Topical drug delivery

Indexed keywords

DRUG CARRIER; ETHOSOME; PACLITAXEL; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; ONCOGENESIS AND MALIGNANT TRANSFORMATION; SQUAMOUS CELL CARCINOMA; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; HUMANS; KERATOSIS, ACTINIC; PACLITAXEL; SKIN ABSORPTION; SKIN NEOPLASMS; TISSUE DISTRIBUTION;

EID: 84861099287     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.02.008     Document Type: Article

References (48)

1. Skin cancer. National Cancer Institute. < http://www.cancer.gov/ cancertopics/types/skin > (accessed 4.03.10).
2. R. Rossi, M. Mori, and T. Lotti Actinic keratosis Int. J. Dermatol. 46 2007 895 904
3. D.R. Bickers, H.W. Lim, D. Margolis, M.A. Weinstock, C. Goodman, E. Faulkner, C. Gould, E. Gemmen, and T. Dall The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology J. Am. Acad. Dermatol. 55 2006 490 500
4. M. Ulrich, D. Krueger-Corcoran, J. Roewert-Huber, W. Sterry, E. Stockfleth, and S. Astner Reflectance confocal microscopy for noninvasive monitoring of therapy and detection of subclinical actinic keratoses Dermatology 220 2010 15 24
5. J.L. Cohen Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer J. Clin. Aesthet. Dermatol. 3 2010 39 44
6. A. Han, C. Penrose, A. Goldsmith, and E.S. Marmur Case-based considerations in the treatment of actinic keratoses: utilizing combination or sequential therapy with 5-fluorouracil cream and destructive treatments J. Drugs Dermatol. 9 2010 864 869
7. H.S. Kim, E.A. Cho, J.M. Bae, D.S. Yu, S.T. Oh, H. Kang, C.J. Park, J.D. Lee, J.Y. Lee, S.Y. Kim, H.O. Kim, and Y.M. Park Recent trend in the incidence of premalignant and malignant skin lesions in Korea between 1991 and 2006 J. Korean Med. Sci. 25 2010 924 929
8. A.C. Halpern, and L.J. Hanson Awareness of, knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians Int. J. Dermatol. 43 2004 638 642
9. S.R. Feldman, A.B. Fleischer Jr., P.M. Williford, and J.L. Jorizzo Destructive procedures are the standard of care for treatment of actinic keratoses J. Am. Acad. Dermatol. 40 1999 43 79
10. J.M. Weinberg Topical therapy for actinic keratoses: current and evolving therapies Rev. Recent Clin. Trials 1 2006 53 60
11. A. Stritt, H.F. Merk, L.R. Braathen, and V. von Felbert Photodynamic therapy in the treatment of actinic keratosis Photochem. Photobiol. 84 2008 388 398
12. L. Li, S. Shukla, A. Lee, S.H. Garfield, D.J. Maloney, S.V. Ambudkar, and S.H. Yuspa The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature Cancer Res. 70 2010 4509 4519
13. L. Resnick, H. Rabinovitz, D. Binninger, M. Marchetti, and H. Weissbach Topical sulindac combined with hydrogen peroxide in the treatment of actinic keratoses J. Drugs Dermatol. 8 2009 29 32
14. A.Y. Moore Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders J. Dermatolog. Treat. 20 2009 328 335
15. F. Makdsi, and R. Deversa Inflammation of actinic keratosis with combination of alkylating and taxane agents: a case report Cases J. 2 2009 6946 6949
16. J.M. Hosmer, S.H. Shin, A. Nornoo, H. Zheng, and L.B. Lopes Influence of internal structure and composition of liquid crystalline phases on topical delivery of paclitaxel J. Pharm. Sci. 100 2011 1444 1455
17. R. Panchagnula, H. Desu, A. Jain, and S. Khandavilli Effect of lipid bilayer alteration on transdermal delivery of a high-molecular-weight and lipophilic drug: studies with paclitaxel J. Pharm. Sci. 93 2004 2177 2183
18. K. Iwase, Y. Oyama, T. Tatsuishi, J.Y. Yamaguchi, Y. Nishimura, A. Kanada, M. Kobayashi, Y. Maemura, S. Ishida, and Y. Okano Cremophor EL augments the cytotoxicity of hydrogen peroxide in lymphocytes dissociated from rat thymus glands Toxicol. Lett. 154 2004 143 148
19. S. Khandavilli, and R. Panchagnula Nanoemulsions as versatile formulations for paclitaxel delivery: peroral and dermal delivery studies in rats J. Invest. Dermatol. 127 2007 154 162
20. S. Singh, and A.K. Dash Paclitaxel in cancer treatment: perspectives and prospects of its delivery challenges Crit. Rev. Ther. Drug Carrier Syst. 26 2009 333 372
21. D. Cosco, C. Celia, F. Cilurzo, E. Trapasso, and D. Paolino Colloidal carriers for the enhanced delivery through the skin Expert Opin. Drug Deliv. 5 2008 737 755
22. E. Touitou, N. Dayan, L. Bergelson, B. Godin, and M. Eliaz Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties J. Control. Rel. 65 2000 403 418
23. M. Lodzki, B. Godin, L. Rakou, R. Mechoulam, R. Gallily, and E. Touitou Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model J. Control. Rel. 93 2003 377 387
24. D. Ainbinder, D. Paolino, M. Fresta, and E. Touitou Drug delivery applications with ethosomes J. Biomed. Nanotechnol. 6 2010 558 568
25. D. Paolino, G. Lucania, D. Mardente, F. Alhaique, and M. Fresta Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers J. Control. Rel. 106 2005 99 110
26. B. Godin, and E. Touitou Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier J. Control. Rel. 94 2004 365 379
27. B. Godin, and E. Touitou Ethosomes: new prospects in transdermal delivery Crit. Rev. Ther. Drug Carrier Syst. 20 2003 63 102
28. Y. Kitajima, S. Inoue, S. Nagao, K. Nagata, H. Yaoita, and Y. Nozawa Biphasic effects of 12-O-tetradecanoylphorbol-13-acetate on the cell morphology of low-calcium-grown human epidermal carcinoma cells: involvement of translocation and down-regulation of protein kinase C Cancer Res. 48 1988 964 970
29. R. Pignatello, D. Paolino, V. Pantò, V. Pistarà, M.G. Calvagno, D. Russo, G. Puglisi, and M. Fresta Lipoamino acid prodrugs of paclitaxel: synthesis and cytotoxicity evaluation on human anaplastic thyroid carcinoma cells Curr. Cancer Drug Targets 9 2009 202 213
30. A.M. Kligman, and E. Christophers Preparation of isolated sheets of human stratum corneum Arch. Dermatol. 88 1963 702 705
31. A. Saija, A. Tomaino, D. Trombetta, A. De Pasquale, N. Uccella, T. Barbuzzi, D. Paolino, and F. Bonina In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents Int. J. Pharm. 199 2000 39 47
32. M. Fresta, and G. Puglisi Application of liposomes as potential cutaneous drug delivery. In vitro and in vivo investigation with radioactively labelled vesicles J. Drug Target. 4 1996 95 101
33. M. Manconi, C. Sinico, C. Caddeo, A.O. Vila, D. Valenti, and A.M. Fadda Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin Int. J. Pharm. 412 2011 37 46
34. D.W. Hedley, T.V. Shankey, and L.L. Wheeless DNA cytometry consensus conference Cytometry 14 1993 471
35. N. Dayan, and E. Touitou Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes Biomaterials 21 2000 1879 1885
36. B. Godin, and E. Touitou Erythromycin ethosomal systems: physicochemical characterization and enhanced antibacterial activity Curr. Drug Deliv. 2 2005 269 275
37. T. Yang, F.D. Cui, M.K. Choi, J.W. Cho, S.J. Chung, C.K. Shim, and D.D. Kim Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation Int. J. Pharm. 338 2007 317 326
38. P. Crosasso, M. Ceruti, P. Brusa, S. Arpicco, F. Dosio, and L. Cattel Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes J. Control. Rel. 63 2000 19 30
39. D. Mishra, P.K. Mishra, S. Dabadghao, V. Dubey, M. Nahar, and N.K. Jain Comparative evaluation of hepatitis B surface antigen-loaded elastic liposomes and ethosomes for human dendritic cell uptake and immune response Nanomedicine 6 2010 110 118
40. C. Guo, S. Liu, Z. Dai, C. Jiang, and W. Li Polydiacetylene vesicles as a novel drug sustained-release system Colloids Surf. B Biointerfaces 76 2010 362 365
41. S. Li, B. Byrne, J. Welsh, and A.F. Palmer Self-assembled poly(butadiene)-b-poly(ethylene oxide) polymersomes as paclitaxel carriers Biotechnol. Prog. 23 2007 278 285
42. T. Yang, M.K. Choi, F.D. Cui, J.S. Kim, S.J. Chung, C.K. Shim, and D.D. Kim Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome J. Control. Rel. 120 2007 169 177
43. Y.P. Fang, Y.B. Huang, P.C. Wu, and Y.H. Tsai Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior Eur. J. Pharm. Biopharm. 73 2009 391 398
44. D. Ainbinder, and E. Touitou Testosterone ethosomes for enhanced transdermal delivery Drug Deliv. 12 2005 297 303
45. V. Dubey, D. Mishra, and N.K. Jain Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery Eur. J. Pharm. Biopharm. 67 2007 398 405
46. V. Dubey, D. Mishra, M. Nahar, and N.K. Jain Vesicles as tools for the modulation of skin permeability Expert Opin. Drug Deliv. 4 2007 579 593
47. S. Jain, A.K. Tiwary, B. Sapra, and N.K. Jain Formulation and evaluation of ethosomes for transdermal delivery of lamivudine AAPS PharmSciTech 8 2007 249 257
48. J. Kovár, M. Ehrlichová, B. Smejkalová, I. Zanardi, I. Ojima, and I. Gut Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells Anticancer Res. 29 2009 2951 2960